Melanotan II

Melanotan II is a cyclic heptapeptide originally developed as part of research into synthetic analogs of alpha-melanocyte-stimulating hormone (alpha-MSH), a naturally occurring hormone involved in regulating melanin production. Unlike alpha-MSH itself, Melanotan II was engineered with a cyclic structure that confers greater metabolic stability and receptor-binding affinity, making it a useful pharmacological tool for studying the melanocortin receptor system.

Mechanism of action

Melanotan II is characterized in the receptor-pharmacology literature as a non-selective agonist across multiple melanocortin receptor (MCR) subtypes, most notably MC1R and MC4R. MC1R activation on melanocytes is the receptor pathway most directly linked to melanin synthesis, which is the basis for Melanotan II's use in pigmentation research models. MC4R, by contrast, is expressed primarily in the central nervous system and is implicated in a separate body of research literature concerning appetite regulation and sexual function — which is why Melanotan II's research applications extend well beyond pigmentation alone, into broader melanocortin-receptor-system studies.

This receptor non-selectivity is a key point researchers emphasize: because Melanotan II activates multiple melanocortin receptors simultaneously, it produces a broader and less tissue-specific research signal than compounds engineered for single-receptor selectivity, which has motivated the development of more selective melanocortin analogs in subsequent pharmacological research.

What the research literature reports

Published research on Melanotan II spans pigmentation studies examining melanin synthesis pathways, and a separate strand of literature examining MC4R-mediated effects relevant to energy balance and sexual behavior in animal models. The compound has also appeared in erectile-function research literature, an application that traces back to MC4R's role in central nervous system pathways governing that response — research that historically contributed to the development of a related, more receptor-selective compound for that specific application.

As with other compounds in this encyclopedia, the majority of Melanotan II's foundational mechanistic literature derives from receptor-binding assays and animal-model studies rather than large-scale controlled human trials, and researchers typically frame findings accordingly.

Melanotan II's non-selective melanocortin receptor activity is what gives it a research footprint well beyond pigmentation alone.

Relationship to other melanocortin research

Melanotan II is often discussed as a precursor concept to more receptor-selective melanocortin analogs later developed for specific single-pathway research and applications. Understanding its non-selective, multi-receptor pharmacology is considered foundational background for interpreting research on those later, more targeted compounds.

Handling & sourcing notes

Melanotan II is supplied as a lyophilized powder requiring reconstitution before laboratory use. Standard cold-chain and light-protection storage practices apply, consistent with other peptides cataloged in this encyclopedia. See our methodology page for our approach to evaluating supplier documentation and purity claims.

Summary

• Melanotan II is a cyclic synthetic analog of alpha-MSH with non-selective melanocortin receptor agonist activity.
• Its research relevance spans MC1R-mediated pigmentation pathways and MC4R-mediated central nervous system pathways.
• Published literature covers pigmentation, energy-balance, and sexual-function research models.
• It is considered a foundational compound for understanding later, more receptor-selective melanocortin research.